GR860398B - Process for obtaining peptidic derivatives of renine inhibitors and proteases acids - Google Patents

Process for obtaining peptidic derivatives of renine inhibitors and proteases acids

Info

Publication number
GR860398B
GR860398B GR860398A GR860100398A GR860398B GR 860398 B GR860398 B GR 860398B GR 860398 A GR860398 A GR 860398A GR 860100398 A GR860100398 A GR 860100398A GR 860398 B GR860398 B GR 860398B
Authority
GR
Greece
Prior art keywords
proteases
acids
obtaining
peptidic derivatives
renine
Prior art date
Application number
GR860398A
Other languages
English (en)
Inventor
Wagnon Jean
Callet Georges
Gagnol Pierre-Jean
Cazaubon Catherine
Nisato Dino
Original Assignee
Sanofi Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8501982A external-priority patent/FR2577226B1/fr
Priority claimed from FR8501981A external-priority patent/FR2577225B1/fr
Application filed by Sanofi Sa, Inst Nat Sante Rech Med filed Critical Sanofi Sa
Publication of GR860398B publication Critical patent/GR860398B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR860398A 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives of renine inhibitors and proteases acids GR860398B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8501982A FR2577226B1 (fr) 1985-02-12 1985-02-12 Analogues de pepstatine inhibiteurs de la renine et des proteases acides
FR8501981A FR2577225B1 (fr) 1985-02-12 1985-02-12 Derives peptidiques inhibiteurs de la renine et des proteases acides

Publications (1)

Publication Number Publication Date
GR860398B true GR860398B (en) 1986-06-12

Family

ID=26224369

Family Applications (2)

Application Number Title Priority Date Filing Date
GR860399A GR860399B (en) 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids
GR860398A GR860398B (en) 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives of renine inhibitors and proteases acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR860399A GR860399B (en) 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids

Country Status (11)

Country Link
US (2) US4725580A (el)
EP (2) EP0192554B1 (el)
AT (2) ATE52518T1 (el)
AU (2) AU606572B2 (el)
CA (2) CA1286846C (el)
DE (2) DE3671021D1 (el)
DK (2) DK64086A (el)
ES (2) ES8701783A1 (el)
GR (2) GR860399B (el)
NZ (2) NZ215096A (el)
PT (2) PT81991B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585708B1 (fr) * 1985-07-31 1989-07-07 Sanofi Sa Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
DE3626130A1 (de) * 1986-08-01 1988-02-11 Merck Patent Gmbh Aminosaeurederivate
DE3640535A1 (de) * 1986-11-27 1988-06-01 Merck Patent Gmbh Peptide
EP0284510A3 (en) * 1987-03-24 1990-08-22 Asahi Breweries, Ltd. N-[N alpha-(1(S)-carboxy-3-cyclohexyl-propyl)-1-lysyl] N-cyclopentylglycine as antihypertensives
US4874745A (en) * 1987-10-01 1989-10-17 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US4980283A (en) * 1987-10-01 1990-12-25 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US5162527A (en) * 1987-10-26 1992-11-10 Warner-Lambert Company Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
KR890701619A (ko) * 1987-10-26 1989-12-22 크리스틴 에이.트러트웨인 레닌 억제제, 그의 제조 방법, 그 사용 방법 및 이들을 함유한 조성물
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
ATE124867T1 (de) * 1989-02-16 1995-07-15 Sankyo Co Peptide, die eine reninhemmende aktivität besitzen, deren herstellung und verwendung.
FR2646354B1 (fr) * 1989-04-27 1994-06-10 Sanofi Sa Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
US5238923A (en) * 1989-05-26 1993-08-24 Warner-Lambert Company Amino-substituted heterocycles as renin inhibitors
US5149692A (en) * 1989-12-21 1992-09-22 Warner-Lambert Company Bisalkoxyphosphinyl compounds as renin inhibitors
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
AT407043B (de) * 1998-01-23 2000-11-27 Martin Dr Kratzel Simplifizierte pepstatin-a-analoga, deren herstellung und verwendung
US7247704B2 (en) * 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
US7929913B2 (en) 2002-12-16 2011-04-19 Intel Corporation Adaptive receiver architecture
BR112013020025A2 (pt) 2011-02-08 2017-03-21 Merck Patent Gmbh derivados de aminoestatina para o tratamento de artrose
US9624264B2 (en) 2012-07-24 2017-04-18 Merck Patent Gmbh Hydroxystatin derivatives for the treatment of arthrosis
CA2902080A1 (en) 2013-02-25 2014-08-28 Merck Patent Gmbh 2-amino-3,4-dihydroquinazoline derivatives and the use thereof as cathepsin d inhibitors
CN105451754A (zh) 2013-08-06 2016-03-30 默克专利股份有限公司 在关节病的情况下胃酶抑素的关节内施用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
DE3381565D1 (de) * 1982-12-27 1990-06-21 Merck & Co Inc Reninhemmende tripeptide.

Also Published As

Publication number Publication date
EP0193445B1 (fr) 1990-05-09
AU606572B2 (en) 1991-02-14
ES8701783A1 (es) 1987-01-01
GR860399B (en) 1986-06-12
DE3683170D1 (de) 1992-02-13
DE3671021D1 (de) 1990-06-13
ATE71111T1 (de) 1992-01-15
ES8701782A1 (es) 1986-12-16
ES551821A0 (es) 1987-01-01
PT81991A (fr) 1986-03-01
NZ215096A (en) 1989-10-27
EP0192554A1 (fr) 1986-08-27
DK64186A (da) 1986-08-13
PT81990A (fr) 1986-03-01
US4725580A (en) 1988-02-16
ES551820A0 (es) 1986-12-16
ATE52518T1 (de) 1990-05-15
EP0193445A1 (fr) 1986-09-03
US4746648A (en) 1988-05-24
DK64186D0 (da) 1986-02-10
CA1286846C (en) 1991-07-23
PT81991B (pt) 1988-03-03
DK64086D0 (da) 1986-02-10
PT81990B (pt) 1988-03-03
NZ215097A (en) 1990-04-26
AU5327286A (en) 1986-08-14
EP0192554B1 (fr) 1992-01-02
CA1286847C (en) 1991-07-23
AU5327386A (en) 1986-08-21
AU606312B2 (en) 1991-02-07
DK64086A (da) 1986-08-13

Similar Documents

Publication Publication Date Title
GR860398B (en) Process for obtaining peptidic derivatives of renine inhibitors and proteases acids
PT87652A (pt) Process for the preparation of peptide bobonic acid inhibitors of trypsin-like proteases
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
NZ214457A (en) Peptide inhibitor of serine protease
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
DE3462039D1 (en) Peptide derivatives, their preparation and use as elastase inhibitors
EP0187721A3 (en) Preparation of peptide substrates for virus-specified proteases
GR862021B (en) Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases
EP0209897A3 (en) Peptide enzyme inhibitors
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
GR860532B (en) Process for obtainig peptidic derivtives of renine aminoalcohols inhibitor and acid proteases
EP0156319A3 (en) Renin inhibitors containing homophe 8
HU890380D0 (en) Process for producing (mercapto-acyl)-amino acid derivatives and pharmaceutical preparatives containing these compounds
GB2111055B (en) N-(vinblastinoyl-23) derivative of amino acids
EP0156320A3 (en) Renin inhibitors containing homophe 8 and a c-terminal amide cycle
DE3568298D1 (en) Process for hydrolysis of peptide or protein
ZA86961B (en) Peptide derivatives which inhibit renin and acid proteases
JPS6426596A (en) Homocyclostatin as hypotensive agent and cyclostatin-containing polypeptide
ZA883953B (en) Peptide boronic acid inhibitors of trypsin-like proteases
IT8419056A1 (it) Procedimento per l'isolamento di L-amminoacidi
YU43890B (en) Process for obtaining metalohelate of amino acids